The number of nephrons in different glomerular diseases.
Blood pressure
Diabetic nephropathy
IgA nephropathy
Membranous nephropathy
Minimal change disease
Nephritic syndrome
Nephron number
Nephrotic syndrome
Podocytes
eGFR
Journal
PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
04
2019
accepted:
07
08
2019
entrez:
20
9
2019
pubmed:
20
9
2019
medline:
20
9
2019
Statut:
epublish
Résumé
The total number of nephrons has been measured mainly from post-mortem studies and only in selected populations. Data from living subjects are scanty, and direct comparisons among different glomerular diseases are lacking. The present work exploits modern methodology to estimate the total nephron number in glomerulopathies with prevalent proteinuria/nephrotic syndrome versus glomerulopathies with nephritic syndrome (IgA nephropathy (IgAN), lupus nephritis), thus extending previous observations about the number and function of glomeruli in different physiological and pathological states. This is a retrospective study based on one hundred and seven patients who have undergone renal biopsy. The glomerular density has been estimated from the biopsy specimens and the total cortical volume has been obtained from ultrasound recordings. Stereological methods have been applied to calculate the total number of nephrons and their volume. The correlation between clinical parameters and quantitative morphological data have studied using the Pearson correlation coefficient ( The total number of nephrons inversely correlated with the systolic blood pressure ( The fusion of the podocyte foot-processes that typically occurs in purely proteinuric diseases does not modify the glomerular filtration rate: therefore in these situations, the change in eGFR depends mainly on the number of available glomeruli. On the other side, the eGFR decrease occurring in nephritic syndromes, such as IgAN, cannot be explained simply on the basis of the number of NSG and likely depends on the substantial involvement of the mesangial axis. Future studies should verify whether these changes are reversible with appropriate therapy, thus reversing eGFR decrease.
Sections du résumé
BACKGROUND
BACKGROUND
The total number of nephrons has been measured mainly from post-mortem studies and only in selected populations. Data from living subjects are scanty, and direct comparisons among different glomerular diseases are lacking. The present work exploits modern methodology to estimate the total nephron number in glomerulopathies with prevalent proteinuria/nephrotic syndrome versus glomerulopathies with nephritic syndrome (IgA nephropathy (IgAN), lupus nephritis), thus extending previous observations about the number and function of glomeruli in different physiological and pathological states.
METHODS
METHODS
This is a retrospective study based on one hundred and seven patients who have undergone renal biopsy. The glomerular density has been estimated from the biopsy specimens and the total cortical volume has been obtained from ultrasound recordings. Stereological methods have been applied to calculate the total number of nephrons and their volume. The correlation between clinical parameters and quantitative morphological data have studied using the Pearson correlation coefficient (
RESULTS
RESULTS
The total number of nephrons inversely correlated with the systolic blood pressure (
DISCUSSION
CONCLUSIONS
The fusion of the podocyte foot-processes that typically occurs in purely proteinuric diseases does not modify the glomerular filtration rate: therefore in these situations, the change in eGFR depends mainly on the number of available glomeruli. On the other side, the eGFR decrease occurring in nephritic syndromes, such as IgAN, cannot be explained simply on the basis of the number of NSG and likely depends on the substantial involvement of the mesangial axis. Future studies should verify whether these changes are reversible with appropriate therapy, thus reversing eGFR decrease.
Identifiants
pubmed: 31534861
doi: 10.7717/peerj.7640
pii: 7640
pmc: PMC6731770
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e7640Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Am J Physiol Renal Physiol. 2000 May;278(5):F817-22
pubmed: 10807594
Diabetologia. 1975 Jun;11(3):225-9
pubmed: 1149955
N Engl J Med. 2003 Jan 9;348(2):101-8
pubmed: 12519920
Kidney Int Suppl. 2003 Feb;(83):S31-7
pubmed: 12864872
Am J Med. 1960 Jan;28:77-98
pubmed: 13804370
J Appl Physiol. 1962 Mar;17:343-8
pubmed: 14005589
J Am Soc Nephrol. 2003 Oct;14(10):2662-8
pubmed: 14514746
Br Med J. 1952 Jun 21;1(4772):1313-7; contd
pubmed: 14935243
Kidney Int. 2004 Nov;66(5):1901-6
pubmed: 15496161
Kidney Int. 2006 Feb;69(4):671-8
pubmed: 16395270
Kidney Int. 2006 Jun;69(12):2131-47
pubmed: 16688120
J Clin Invest. 1939 Mar;18(2):195-212
pubmed: 16694654
Kidney Int. 1991 Oct;40(4):792-807
pubmed: 1745032
Am J Kidney Dis. 2008 Jul;52(1):18-28
pubmed: 18514988
Clin J Am Soc Nephrol. 2010 Jan;5(1):39-44
pubmed: 19965542
Am J Kidney Dis. 1991 Jun;17(6):666-9
pubmed: 2042646
Nephrol Dial Transplant. 2011 Nov;26(11):3555-60
pubmed: 21771759
Am J Nephrol. 2011;34(6):542-8
pubmed: 22123493
Clin J Am Soc Nephrol. 2012 May;7(5):735-41
pubmed: 22403274
Invest Radiol. 1990 Nov;25(11):1206-11
pubmed: 2254054
Kidney Int. 1990 Jul;38(1):115-23
pubmed: 2385079
Kidney Int. 2014 Mar;85(3):677-85
pubmed: 24067437
Nephrol Dial Transplant. 2014 Jul;29(7):1399-409
pubmed: 24327566
Nephron. 2015;129(4):253-62
pubmed: 25895545
N Engl J Med. 2015 Dec 3;373(23):2225-36
pubmed: 26630142
J Am Soc Nephrol. 2017 Jan;28(1):313-320
pubmed: 27401688
Nephron. 2017;136(2):151-157
pubmed: 28329736
N Engl J Med. 2017 Jun 15;376(24):2349-2357
pubmed: 28614683
Lancet. 1986 May 10;1(8489):1077-81
pubmed: 2871345
JCI Insight. 2017 Oct 5;2(19):
pubmed: 28978800
J Am Soc Nephrol. 2018 Jan;29(1):317-325
pubmed: 29042456
Clin Exp Nephrol. 2018 Jun;22(3):603-612
pubmed: 29071505
BMC Nephrol. 2018 Mar 14;19(1):62
pubmed: 29540159
Am J Hypertens. 1988 Oct;1(4 Pt 1):335-47
pubmed: 3063284
J Nephrol. 2019 Jun;32(3):411-415
pubmed: 30778919
BMJ. 1988 Jul 9;297(6641):134-5
pubmed: 3408942
Am J Physiol. 1974 Sep;227(3):556-62
pubmed: 4412873
Am J Physiol. 1981 Jul;241(1):F85-93
pubmed: 7246778
BMJ. 1993 Feb 13;306(6875):422-6
pubmed: 8461722
Kidney Int. 1996 Jun;49(6):1774-7
pubmed: 8743495
J Am Soc Nephrol. 1997 Nov;8(11):1668-78
pubmed: 9355069
Nephron. 1998 Nov;80(3):285-91
pubmed: 9807037